Treatment with Scemblix was shown to improve response rates in patients with newly diagnosed Philadelphia chromosome-positive ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells ...

Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...

OOLOGAH, Okla. — An 11-year-old from Oologah battling leukemia is holding a toy drive for kids at his hospital. Jaxon Crabb ...

If you're anything like me, you spiral down the deep, dark hole of WebMD every time you experience even the mildest of ...

The anti-BCMA antibody-drug conjugate (ADC) MEDI2228 demonstrated efficacy against relapsed/refractory multiple myeloma (RRMM), showing the feasibility of this approach, according to the results of a ...

Her rash was petechiae, which are pinpoint-like dots that can develop under the skin of someone with leukemia. Lovell was diagnosed with high-risk acute lymphoblastic leukemia at University of ...

October 2024 brought 4 new FDA drug approvals in the oncology space. With new drug regimens in both the solid tumor and blood ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced upcoming presentations of six posters highlighting data from their ...

Meet Kid Captain Adeline Lovell. The Clear Lake girl was diagnosed with high-risk acute lymphoblastic leukemia, an aggressive ...